Organic nitrate-induced methemoglobinemia

Area of Science:

• Pharmacology
• Toxicology

Background:

• Organic nitrate metabolism generates nitrites, which can oxidize hemoglobin to methemoglobin.
• Methemoglobinemia is a potential adverse effect of organic nitrate therapy.

Purpose of the Study:

• To evaluate the risk of clinically significant methemoglobinemia associated with therapeutic organic nitrate use.
• To identify factors contributing to nitrate-induced methemoglobinemia.

Main Methods:

• Review of clinical trial data on organic nitrate use and methemoglobin levels.
• Analysis of case reports detailing significant methemoglobinemia in patients using organic nitrates.

Main Results:

• Clinical trials indicate organic nitrates modestly increase methemoglobin, generally not to a clinically significant extent.
• Case reports describe significant methemoglobinemia, often with higher nitrate doses, renal dysfunction, or concomitant methemoglobin inducers.
• A clear dose-response relationship could not be established due to study design limitations.

Conclusions:

• While organic nitrates can elevate methemoglobin, significant clinical risk appears low in typical therapeutic use.
• Vigilance for methemoglobinemia symptoms is crucial in patients on organic nitrates, particularly with high doses or predisposing factors.
• Discontinuation of nitrates and methylene blue administration are key treatment strategies for severe cases.